sulfadiazine has been researched along with zithromax in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 9 (34.62) | 29.6817 |
| 2010's | 10 (38.46) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Araujo, FG; Lin, T; Remington, JS | 1 |
| Almadany, R; Chau, F; Derouin, F; Pocidalo, JJ; Rouveix, B | 1 |
| Araujo, FG; Huskinson-Mark, J; Remington, JS | 1 |
| Hazebroucq, V; Joly, V; Leport, C; Morlat, P; Raffi, F; Saba, J; Vildé, JL | 1 |
| Dawson, SJ; Francis, JM; Guy, EC; Joynson, DH; O'Connell, S | 1 |
| Brettle, RP; Burns, SM; Flegg, PJ; Laing, RB; Leen, CL | 1 |
| Bosch-Driessen, LH; Hoyng, CB; Klok, AM; Rothova, A; Suttorp-Schulten, MS; van Ruyven, RL; Verbraak, FD | 1 |
| Booton, GC; Dunnebacke, TH; Schuster, FL; Yagi, S | 1 |
| Mazereeuw-Hautier, J | 1 |
| Akin, L; Ercis, M; Ercis, S; Hasçelik, C; Köseoğlu, O; Salmanzadeh-Ahrabi, S | 1 |
| Angeloni, MB; Barbosa, BF; Costa, IN; Ferro, EA; Magalhães, PM; Mineo, JR; Pena, JD; Rodrigues, AA; Rostkowsa, C; Santana, LA; Silva, DA; Silva, MC | 1 |
| Bernardes, ES; Ferro, EA; Firminot, ML; Lopes, CD; Pena, JD; Roque-Barreira, MC; Silva, NM; Sousa, RA | 1 |
| Balaskas, K; Boillat-Blanco, N; Guex-Crosier, Y; Vaudaux, J | 1 |
| Alves, CM; Angeloni, MB; Barbosa, BF; Castro-Filice, LS; Ferro, EA; Gomes, AO; Martins-Filho, OA; Mineo, JR; Santos, MC; Silva, DA; Silva, NM | 1 |
| Lindsay, DS; Peng, HJ; Wei, HX; Wei, SS | 1 |
| Benhaddou, N; Blanche, P; Brézin, A; Charlier, C; Coutte, L; Dupin, N; Errera, MH; Frumholtz, L; Groh, M; Héron, E; Hoogewoud, F; Launay, O; Le Jeunne, C; Lebeaux, D; Lortholary, O; Loubet, P; Monnet, D; Sahel, JA; Salah, S; Sedira, N; Vanhaecke, C | 1 |
| Angeloni, MB; Barbosa, BF; Castro, AS; Ferro, EAV; Franco, PS; Gomes, AO; Ietta, F; Lopes-Maria, JB; Martins-Filho, OA; Milian, ICB; Mineo, JR; Oliveira, FC; Ribeiro, M; Silva, RJD | 1 |
| Li, B; Si, H; Xu, C; Zhang, J; Zhang, X; Zhou, X | 1 |
| Chen, H; Chen, Y; He, X; Huang, Y; Li, Y; Lu, Y; Wu, Y; Zeng, Y; Zhang, W | 1 |
3 review(s) available for sulfadiazine and zithromax
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Impetigo].
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Azithromycin; Cephalosporins; Child; Clavulanic Acid; Clinical Trials as Topic; Diagnosis, Differential; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Methicillin; Mupirocin; Ointments; Penicillins; Pregnancy; Pristinamycin; Sulfadiazine; Time Factors | 2006 |
A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Antiprotozoal Agents; Azithromycin; Clindamycin; Drug Therapy, Combination; Female; Humans; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pyrimethamine; Spiramycin; Sulfadiazine; Toxoplasma; Toxoplasmosis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
4 trial(s) available for sulfadiazine and zithromax
| Article | Year |
|---|---|
Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Azithromycin; Drug Administration Schedule; Drug Therapy, Combination; Encephalitis; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Cerebral | 1993 |
A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Drug Evaluation; Drug Therapy, Combination; Humans; Middle Aged; Prospective Studies; Pyrimethamine; Safety; Sulfadiazine; Toxoplasmosis, Ocular; Treatment Outcome; Visual Acuity | 2002 |
Azithromycin versus Sulfadiazine and Pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: a pilot study.
Topics: Adult; Antiprotozoal Agents; Azithromycin; Chorioretinitis; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Ocular | 2012 |
Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Azithromycin; Clindamycin; Encephalitis; Humans; Sulfadiazine; Sulfanilamide; Sulfonamides; Toxoplasma; Toxoplasmosis, Cerebral; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
19 other study(ies) available for sulfadiazine and zithromax
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.
Topics: Animals; Azithromycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Mice; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 1992 |
Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
Topics: Animals; Azithromycin; Brain; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Lung; Mice; Pyrimethamine; Sulfadiazine; Survival Rate; Toxoplasmosis, Animal | 1992 |
Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii.
Topics: Adenine; Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Brain; Clindamycin; Coccidiostats; Erythromycin; Fluorouracil; Mice; Mice, Inbred CBA; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma | 1991 |
Chronic active toxoplasmosis in an immunocompetent patient.
Topics: Adult; Azithromycin; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunocompetence; Immunoglobulin M; Lymphatic Diseases; Pyrimethamine; Sulfadiazine; Toxoplasmosis | 1993 |
Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Atovaquone; Autopsy; Azithromycin; Brain; CD4 Lymphocyte Count; Clindamycin; Drug Therapy, Combination; Female; Humans; Incidence; Lymphoma, AIDS-Related; Male; Middle Aged; Naphthoquinones; Pyrimethamine; Retrospective Studies; Sulfadiazine; Toxoplasmosis, Cerebral; United Kingdom | 1996 |
Balamuthia mandrillaris from soil samples.
Topics: Amphotericin B; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Azithromycin; DNA, Mitochondrial; DNA, Protozoan; DNA, Ribosomal; Fluconazole; Flucytosine; Fluorescent Antibody Technique, Indirect; Genes, rRNA; Lobosea; Microscopy; Molecular Sequence Data; Parasitic Sensitivity Tests; Pentamidine; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Soil; Sulfadiazine | 2004 |
[The prevalence of nasopharyngeal Neisseria meningitidis carriage, serogroup distribution, and antibiotic resistance among healthy children in Cankaya municipality schools of Ankara province].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Carrier State; Child; Female; Humans; Male; Meningococcal Infections; Nasopharynx; Neisseria meningitidis; Penicillins; Prevalence; Rifampin; Risk Factors; Serotyping; Sulfadiazine; Turkey | 2005 |
Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Topics: Animals; Antibodies; Artemisia annua; Azithromycin; DNA, Protozoan; Drug Therapy, Combination; Embryo, Mammalian; Female; Immunohistochemistry; Infectious Disease Transmission, Vertical; Leucovorin; Mice; Placenta; Plant Extracts; Polymerase Chain Reaction; Pregnancy; Pyrimethamine; Sigmodontinae; Spiramycin; Sulfadiazine; Toxoplasma; Toxoplasmosis, Congenital | 2009 |
Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
Topics: Animals; Anti-Infective Agents; Antiprotozoal Agents; Azithromycin; Brain; Disease Models, Animal; DNA, Protozoan; Drug Therapy, Combination; Eye; Female; Fetus; Immunohistochemistry; Infectious Disease Transmission, Vertical; Leucovorin; Male; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sigmodontinae; Sulfadiazine; Toxoplasma; Toxoplasmosis, Ocular; Vitamin B Complex | 2009 |
Azithromycin is able to control Toxoplasma gondii infection in human villous explants.
Topics: Azithromycin; Chorionic Villi; Female; Humans; In Vitro Techniques; Leucovorin; Pregnancy; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis | 2014 |
Prognostic Factors in Syphilitic Uveitis.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Doxycycline; Eye Infections, Bacterial; Female; Fluorescent Treponemal Antibody-Absorption Test; Follow-Up Studies; HIV Seropositivity; Humans; Male; Middle Aged; Penicillin G Benzathine; Polymerase Chain Reaction; Prognosis; Retrospective Studies; Sulfadiazine; Syphilis; Syphilis Serodiagnosis; Uveitis; Visual Acuity | 2017 |
Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells.
Topics: Antiprotozoal Agents; Azithromycin; Cell Line, Tumor; Cytokines; Drug Combinations; Genotype; Humans; Interleukin-12; Pyrimethamine; Spiramycin; Sulfadiazine; Toxoplasma; Trophoblasts | 2017 |
Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
Topics: Animals; Antiprotozoal Agents; Azithromycin; Cell Survival; Chalcones; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Microscopy, Electron; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 2018 |